D. Hartwig

发表

Epitheliotrophic capacity of a growth factor preparation produced from platelet concentrates on corneal epithelial cells: a potential agent for the treatment of ocular surface defects?

T. Wedel, G. Geerling, P. Schlenke, 2004, Transfusion.

Effect of various platelet preparations on retinal muller cells.

G. A. Limb, H. Hoerauf, G. Geerling, 2009, Investigative ophthalmology & visual science.

Corneal epitheliotrophic capacity of three different blood-derived preparations.

T. Wedel, G. Geerling, D. Hartwig, 2006, Investigative ophthalmology & visual science.

Topical treatment of ocular surface defects: comparison of the epitheliotrophic capacity of fresh frozen plasma and serum on corneal epithelial cells in an in vitro cell culture model

L. Dibbelt, T. Wedel, G. Geerling, 2005, Transfusion medicine.

An optimised protocol for the production of autologous serum eyedrops

T. Wedel, G. Geerling, D. Hartwig, 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

Autologous serum eye drops for ocular surface disorders

G. Geerling, D. Hartwig, S. MacLennan, 2004, British Journal of Ophthalmology.

In vitro proliferation and differentiation of human CD34+ cells from peripheral blood into mature red blood cells with two different cell culture systems

H. Kirchner, P. Schlenke, P. Lazar-Karsten, 2008, Transfusion.

[Epitheliotrophic capacity of serum eye drops from healthy donors versus serum from immunosuppressed patients with rheumatoid arthritis].

T. Wedel, G. Geerling, M. Müller, 2008, Klinische Monatsblatter fur Augenheilkunde.

Zum Stand der Anwendung von Eigenserum-Augentropfen in Deutschland

B. Seitz, G. Geerling, D. Hartwig, 2008, Der Ophthalmologe.

Autologous serum eye drops for ocular surface disorders

G. Geerling, D. Hartwig, S. MacLennan, 2004, British Journal of Ophthalmology.

[Legal regulations to produce serum eye drops : when is it necessary, and how can it be obtained?].

B. Seitz, F. Grus, G. Geerling, 2008, Der Ophthalmologe.

[Experiences with a centralised national service for autologous serum eyedrops in England].

S. Maclennan, G. Geerling, D. Hartwig, 2008, Der Ophthalmologe.

[Epitheliotrophic capacity of serum and plasma eyedrops. Influence of centrifugation].

L. Dibbelt, T. Wedel, G. Geerling, 2004, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[Autologous serum and alternative blood products for the treatment of ocular surface disorders].

S. Schrader, G. Geerling, D. Hartwig, 2008, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

Febrile and Allergic Reactions after Transfusion of Platelet Concentrates

D. Hartwig, H. Klüter, 2003, Transfusion Medicine and Hemotherapy.

Evidence for de novo synthesis of cytokines and chemokines in platelet concentrates

C. Härtel, M. Müller-Steinhardt, H. Hennig, 2002, Vox sanguinis.

Fetal bradycardia following intrauterine platelet transfusion: might elevated levels of donor soluble CD40 ligand play a role?

U. Gembruch, D. Hartwig, J. Neppert, 2004, Acta obstetricia et gynecologica Scandinavica.

Recommendations for optimized settings of the Amicus Crescendo cell separator for the collection of CD34+ progenitor cells

H. Kirchner, P. Schlenke, I. Dorn, 2004, Transfusion.

Improvement of the precision in CFU-GM and BFU-E counting by flow cytometry-based standardization of short-term culture assays.

H. Kirchner, P. Schlenke, S. Sheikhzadeh, 2001, Journal of hematotherapy & stem cell research.

Pentameric C-reactive protein dissociation on microparticles following myocardial infarction and in the pathogenesis of Alzheimer ’ s disease

H. Schunkert, Tag der Mündlichen, J. Torzewski, 2014 .

Successful long‐term erythrocytapheresis therapy in a patient with symptomatic sickle‐cell disease using an arterio‐venous fistula

H. Kirchner, P. Bucsky, P. Schlenke, 2002, Transfusion Medicine.

Diseased vein grafts express elevated inflammatory cytokine levels compared with atherosclerotic coronary arteries.

U. Schönbeck, H. Sievers, C. Bartels, 2004, The Annals of thoracic surgery.

Zum Stand der Anwendung von Eigenserum-Augentropfen in Deutschland

B. Seitz, G. Geerling, D. Hartwig, 2008, Der Ophthalmologe.

Arzneimittelrechtliche Erlaubnis bei der Herstellung von Serum-Augentropfen

F. Grus, F. Schirra, D. Hartwig, 2008, Der Ophthalmologe.

Epitheliotrophe Kapazität von Serum-Augentropfen gesunder versus immunsupprimierter Patienten mit rheumatoider Arthritis

T. Wedel, G. Geerling, D. Hartwig, 2008, Klinische Monatsblatter fur Augenheilkunde.

Epitheliotrophic Capacity of Blood Products for Corneal Epithelium - Influence of Centrifugation Force and Clotting

G. Geerling, D. Hartwig, P. Herminghaus, 2002 .

[Autologous serum-eye-drops for ocular surface disorders. A literature review and recommendations for their application].

G. Geerling, D. Hartwig, 2002, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.